Natera Announces Broad Clinical Launch of Ultra-Sensitive Signatera™ Genome MRD Test

FREE Breaking News Alerts from StreetInsider.com!

E-mail Address

StreetInsider.com Top Tickers, 9/3/2026

1. PANW
2. GTLB
3. MDB
4. DELL
5. HPE
6. GOOGL
7. AVGO
8. SNOW
9. VRTS
10. SPY

Go back to Natera Announces Broad Clinical Launch of Ultra-Sensitive Signatera™ Genome MRD Test
(NASDAQ: NTRA) Delayed: 325.17 --0 (-0%)
Previous Close $325.17    52 Week High $13.80 
Open $325.17    52 Week Low $6.52 
Day High $325.17    P/E N/A 
Day Low $325.17    EPS $0.00 
Volume 38